Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
Ilseon Hwang, Jeong Won Kim, Kris Ylaya, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
Jing Gao, Yuanzheng Liang, Liang Wang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 269
Targeting tumor-associated macrophages for cancer treatment
Mengjun Li, Linye He, Jing Zhu, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 133
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
Yueshui Zhao, Sipeng Guo, Jian Min Deng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3845-3858
Open Access | Times Cited: 133
Roles of macrophages in tumor development: a spatiotemporal perspective
Mathilde Bied, William W. Ho, Florent Ginhoux, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 983-992
Open Access | Times Cited: 127
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 125
Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
Xiaoyan Sun, Weiran Liu, Leina Sun, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005531-e005531
Open Access | Times Cited: 74
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response
Alexander Coulton, Jun Murai, Danwen Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 17
Cancer immune evasion, immunoediting and intratumour heterogeneity
Malte Roerden, Stefani Spranger
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 7
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
Kim A. Reiss, Mathew G. Angelos, E. Claire Dees, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 4
M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma
Xiaodong Qu, Xingyu Zhao, Kexin Lin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
TIGIT blockade repolarizes AML-associated TIGIT+M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
Franziska Brauneck, Brit Fischer, Marius Witt, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e004794-e004794
Open Access | Times Cited: 43
Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy
Ning Han, Ziyi Yang, Zhong-Xiong Xie, et al.
Phytomedicine (2023) Vol. 112, pp. 154682-154682
Closed Access | Times Cited: 41
Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy
Jialun Li, Zhengya Yue, Minglu Tang, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 1
Closed Access | Times Cited: 40
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
Liu‐Gen Li, Xing‐Chun Peng, Tingting Yu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Macrophage Polarization: An Important Candidate Regulator for Lung Diseases
Lishuang Deng, Zhijie Jian, Tong Xu, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2379-2379
Open Access | Times Cited: 37
HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
Ke Li, Quan Gong, Xudong Xiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Manganese-Enriched Zinc Peroxide Functional Nanoparticles for Potentiating Cancer Immunotherapy
Mengli Zhou, Shuang Liang, Dan Liu, et al.
Nano Letters (2023) Vol. 23, Iss. 22, pp. 10350-10359
Closed Access | Times Cited: 31
A Dihydroartemisinin‐Loaded Nanoreactor Motivates Anti‐Cancer Immunotherapy by Synergy‐Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage
Liu‐Gen Li, Xiaoxin Yang, Hua‐Zhen Xu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 28
Closed Access | Times Cited: 27
Macrophages Phenotype Regulated by IL-6 Are Associated with the Prognosis of Platinum-Resistant Serous Ovarian Cancer: Integrated Analysis of Clinical Trial and Omics
Xiaoqing Wu, Wenping Lü, Chaojie Xu, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 25
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma
Shabana Habib, Gabriel Osborn, Zena Willsmore, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 8, pp. 895-911
Open Access | Times Cited: 10
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression
Hussein Sabit, Borros Arneth, Shaimaa Abdel-Ghany, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1666-1666
Open Access | Times Cited: 8
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Henriette Mathiesen, Kristian Juul‐Madsen, Trine Tramm, et al.
Immunology Letters (2025), pp. 106970-106970
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top